Biblio

Found 25 results
Filters: Keyword is Cardiovascular Diseases  [Clear All Filters]
2012
Guarrera S, Ricceri F, Polidoro S, Sacerdote C, Allione A, Rosa F, Voglino F, Critelli R, Russo A, Vineis P et al..  2012.  Association between total number of deaths, diabetes mellitus, incident cancers, and haplotypes in chromosomal region 8q24 in a prospective study.. Am J Epidemiol. 175(6):479-87.
Ezzati M, Riboli E.  2012.  Can noncommunicable diseases be prevented? Lessons from studies of populations and individuals. Science. 337(6101):1482-7.
Mitchell GF, Verwoert GC, Tarasov KV, Isaacs A, Smith AV, Smith AV, Rietzschel ER, Tanaka T, Liu Y, Parsa A et al..  2012.  Common genetic variation in the 3'-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium.. Circ Cardiovasc Genet. 5(1):81-90.
Froguel P, Ndiaye N C, Bonnefond A, Bouatia-Naji N, Dechaume A, Siest G, Herbeth B, Falchi M, Bottolo L, Guéant-Rodriguez R-M et al..  2012.  A genome-wide association study identifies rs2000999 as a strong genetic determinant of circulating haptoglobin levels.. PLoS One. 7(3):e32327.
Pinola P, Lashen H, Bloigu A, Puukka K, Ulmanen M, Ruokonen A, Martikainen H, Pouta A, Franks S, Hartikainen A-L et al..  2012.  Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study. Hum Reprod. 27(11):3279-86.
Asaria P, Fortunato L, Fecht D, Tzoulaki I, Abellan J J, Hambly P, de Hoogh K, Ezzati M, Elliott P.  2012.  Trends and inequalities in cardiovascular disease mortality across 7932 English electoral wards, 1982-2006: Bayesian spatial analysis.. Int J Epidemiol. 41(6):1737-49;discussion1750-2.
2011
Worth H, Chung K F, Felser JM, Hu H, Rueegg P.  2011.  Cardio- and cerebrovascular safety of indacaterol vs formoterol, salmeterol, tiotropium and placebo in COPD.. Respir Med. 105(4):571-9.
Pitcher A, Ashby D, Elliott P, Petersen SE.  2011.  Cardiovascular MRI in clinical trials: expanded applications through novel surrogate endpoints.. Heart. 97(16):1286-92.
Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, Smith AV, Tobin MD, Verwoert GC, Hwang S-J et al..  2011.  Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk.. Nature. 478(7367):103-9.
Oza S, Thun MJ, Henley JS, Lopez AD, Ezzati M.  2011.  How many deaths are attributable to smoking in the United States? Comparison of methods for estimating smoking-attributable mortality when smoking prevalence changes. Prev Med. 52(6):428-33.
Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, Lu C, Pellikka N, Wallaschofski H, Kettunen J, Henneman P et al..  2011.  Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels.. Circulation. 123(7):731-8.
Ashrafian H, Ahmed K, Rowland SP, Patel VM, Gooderham NJ, Holmes E, Darzi A, Athanasiou T.  2011.  Metabolic surgery and cancer: protective effects of bariatric procedures.. Cancer. 117(9):1788-99.
Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ, Farzadfar F, Stevens GA, Lim SS, Riley LM et al..  2011.  National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants.. Lancet. 377(9765):568-77.